The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
Open accessAbstract
Despite the continuous advancement in neurosciences as well as in the knowledge of human behaviors pathophysiology, currently suicide represents a puzzling challenge. The World Health Organization (WHO) has established that one million people die by suicide every year, with the impressive daily rate of a suicide every 40 s. The weightiest concern about suicidal behavior is how difficult it is for healthcare professionals to predict. However, recent evidence in genomic studies has pointed out the essential role that genetics could play in influencing person’s suicide risk. Combining genomic and clinical risk assessment approaches, some studies have identified a number of biomarkers for suicidal ideation, which are involved in neural connectivity, neural activity, mood, as well as in immune and inflammatory response, such as the mammalian target of rapamycin (mTOR) signaling. This interesting discovery provides the neurobiological bases for the use of drugs that impact these specific signaling pathways in the treatment of suicidality, such as ketamine. Ketamine, an N-methyl-d-aspartate glutamate (NMDA) antagonist agent, has recently hit the headlines because of its rapid antidepressant and concurrent anti-suicidal action. Here we review the preclinical and clinical evidence that lay the foundations of the efficacy of ketamine in the treatment of suicidal ideation in mood disorders, thereby also approaching the essential question of the understanding of neurobiological processes of suicide and the potential therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Serotonin transporter genetic variation and the response of the human amygdala.
Hariri, A. R., Mattay, V. S., Tessitore, A., Kolachana, B., Fera, F., Goldman, D., Egan, M. F., & Weinberger, D. R. (2002) · Science · doi:10.1126/science.1071829 · Cited by 2,340
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Psychiatric diagnoses in 3275 suicides: a meta-analysis
Arsenault-Lapierre, G., Kim, C., & Turecki, G. (2004) · BMC Psychiatry · doi:10.1186/1471-244x-4-37 · Cited by 985
Koenigs, M., & Grafman, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.004 · Cited by 956 · cited 1×
“Functional studies have associated the deficits in cognitive flexibility showed by depressed patients to specific alterations in the structure and connection of the prefrontal cortex (PFC) [44,45].”
BackgroundHasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Zarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811 · cited 1×
“[125], who demonstrated that the first effects on depressive symptoms and suicidal thoughts may be seen only 40 min after ketamine injection (0.”
BackgroundSuicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew
Bostwick, J. M., Pabbati, C., Geske, J. R., & McKean, A. J. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15070854 · Cited by 759 · cited 1×
“Furthermore, suicide attempts may be considered a significant risk factor for possible completed suicide [21].”
BackgroundCanuso, C. M., Singh, J. B., Fedgchin, M., Alphs, L., Lane, R., Lim, P., Pinter, C., Hough, D., Sanacora, G., Manji, H., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17060720 · Cited by 676
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., Summergrad, P., Nemeroff, C. B., & for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0080 · Cited by 576
Moghaddam, B. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13387.x · Cited by 567
Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory
Yuen, E. Y., Liu, W., Karatsoreos, I. N., Feng, J., McEwen, B. S., & Yan, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906791106 · Cited by 481 · cited 1×
“In animal models, acute stress may enhance glutamate neurotransmission in PFC [48], and the increase in glutamate-mediated activation may potentiate working memory performances [49], whereas NMDA blocking impairs cognitive flexibility [50].”
BackgroundThe gender paradox in suicidal behavior and its impact on the suicidal process
Schrijvers, D. L., Bollen, J., & Sabbe, B. G. C. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.050 · Cited by 477 · cited 1×
“Recent research breaks down suicidal behavior into its chronological parts: the ideation, the planning, the attempt/attempts, and the complete suicide [15].”
BackgroundGrunebaum, M. F., Galfalvy, H. C., Choo, T.-H., Keilp, J. G., Moitra, V. K., Parris, M. S., Marver, J. E., Burke, A. K., Milak, M. S., Sublette, M. E., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17060647 · Cited by 431 · cited 2×
“This may be somewhat problematic, even if the employed dosages in randomized trials were very low, as it may promote abuse in predisposed subjects as reported after the conclusion of one trial [128] and other observations [138,139].”
BackgroundResultFeyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.005 · Cited by 421 · cited 1×
“essential in NMDA trafficking and transductional pathways, thus suggesting abnormalities in the whole glutamate signaling in brain areas deputed to cognitive tasks [47].”
BackgroundVollenweider, F. X., Leenders, K. L., Øye, I., Hell, D., & Angst, J. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00042-9 · Cited by 413
Liu, R.-J., Lee, F. S., Li, X.-Y., Bambico, F., Duman, R. S., & Aghajanian, G. K. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.030 · Cited by 403
Zhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.005 · Cited by 390 · cited 1×
“Also, ketamine action on mTOR-dependent pathways may further contribute to its rapid effects [148,149].”
BackgroundCognitive therapy for suicidal patients: Scientific and clinical applications.
Wenzel, A., Brown, G. K., & Beck, A. T. (2009) · doi:10.1037/11862-000 · Cited by 369 · cited 1×
“Indeed, different studies have reported that often psychiatric patients pay much attention to environmental cues that are specifically related to their suffering, and in particular the sense of hopelessness, burdensomeness, and loneliness may cause extreme difficulties in patients to find solutions to their problems o…”
BackgroundThe suicidal mind and brain: A review of neuropsychological and neuroimaging studies
Jollant, F., Lawrence, N. L., Olié, E., Guillaume, S., & Courtet, P. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.556200 · Cited by 363 · cited 1×
“(ventrolateral orbital cortex, dorsolateral/dorsomedial prefrontal cortex, anterior cingulate gyrus) [31], and probably to involve glutamatergic neurotransmission dysregulation in these areas [32].”
BackgroundMiller, O. H., Yang, L., Wang, C.-C., Hargroder, E. A., Zhang, Y., Delpire, E., & Hall, B. J. (2014) · eLife · doi:10.7554/elife.03581 · Cited by 358
Keilp, J. G., Gorlyn, M., Russell, M., Oquendo, M. A., Burke, A. K., Harkavy-Friedman, J., & Mann, J. J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001419 · Cited by 350 · cited 1×
“These results confirm previous findings of worse performances in memory, attention and working-memory tasks by non-violent, depressed patients who have attempted suicide in the past, as compared to depressed non-attempters, and suggest that executive dysfunctions in people who have attempted suicide may be related to…”
ResultMcGirr, A., Renaud, J., Bureau, A., Seguin, M., Lesage, A., & Turecki, G. (2008) · Psychological Medicine · doi:10.1017/s0033291707001419 · Cited by 332
Celada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs · doi:10.1007/s40263-013-0071-0 · Cited by 323 · cited 1×
“Moreover, the well-known modulation by clozapine of 5HT1a receptors, which leads to an increase in PFC dopamine release, has been involved in the clinical efficacy of this drug on both negative and cognitive symptoms of schizophrenia, whose treatment-refractoriness has been associated in turn to the propension to suic…”
BackgroundToward a Biosignature for Suicide
Oquendo, M. A., Sullivan, G. M., Sudol, K., Baca-Garcia, E., Stanley, B. H., Sublette, M. E., & Mann, J. J. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14020194 · Cited by 299
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
Murrough, J. W., Soleimani, L., DeWilde, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., Lener, M., Kautz, M., Kim, J., Stern, J. B., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001506 · Cited by 297
Population genetic study of the brain-derived neurotrophic factor (BDNF) gene
Petryshen, T. L., Sabeti, P. C., Aldinger, K. A., Fry, B., Fan, J. B., Schaffner, S. F., Waggoner, S. G., Tahl, A. R., & Sklar, P. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.24 · Cited by 267
Fuchikami, M., Thomas, A., Liu, R., Wohleb, E. S., Land, B. B., DiLeone, R. J., Aghajanian, G. K., & Duman, R. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414728112 · Cited by 265 · cited 1×
“Indeed, ketamine microinfusion in infralimbic PFC has been demonstrated to be able to mimic the antidepressant effects of systemic ketamine infusion, and these effects may be also mimicked by optogenetic stimulation of the same brain area, being related to the increase in number and function of spine synapses of layer…”
BackgroundSynaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
Kavalali, E. T., & Monteggia, L. M. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040531 · Cited by 258
Liu, R.-J., Fuchikami, M., Dwyer, J. M., Lepack, A. E., Duman, R. S., & Aghajanian, G. K. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.128 · Cited by 256 · cited 1×
“of lithium—a well-established GSK3 inhibitor—may potentiate the antidepressant effects of ketamine and increase its anti-oxidative action in PFC of animal models of depressive behaviors [91,92].”
BackgroundLarge, M., Kaneson, M., Myles, N., Myles, H., Gunaratne, P., & Ryan, C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156322 · Cited by 248 · cited 1×
“, displaying multiple suicide-related characteristics defining a high propensity to suicidal mortality) usually do not attempt suicide, whereas 50% of low-risk patients do, thus confirming the complexity of suicidal behavior processes [14].”
BackgroundOxford Textbook of Suicidology and Suicide Prevention
(2009) · doi:10.1093/med/9780198570059.001.0001 · Cited by 240
Grunebaum, M. F., Ellis, S. P., Keilp, J. G., Moitra, V. K., Cooper, T. B., Marver, J. E., Burke, A. K., Milak, M. S., Sublette, M. E., Oquendo, M. A., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12487 · Cited by 174
Czyz, E. K., & King, C. A. (2015) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2013.836454 · Cited by 165
Antidepressant actions of ketamine: from molecular mechanisms to clinical practice
Monteggia, L. M., & Zarate, C. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.12.004 · Cited by 149
Hu, Y.-D., Xiang, Y.-T., Fang, J.-X., Zu, S., Sha, S., Shi, H., Ungvari, G. S., Correll, C. U., Chiu, H. F. K., Xue, Y., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291715002159 · Cited by 146
Jett, J. D., Bulin, S. E., Hatherall, L. C., McCartney, C. M., & Morilak, D. A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.017 · Cited by 92
Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits
Beurel, E., & Jope, R. S. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.129 · Cited by 92 · cited 14×
“NMDAR, N- ethyl-D-aspartate glutamate receptor; AMPAR, α- mi o-3-hydroxy-5-methyl-4-isoxazole ropionic acid glutama e receptor; mGluR1a/5, metabotropic glutamate receptor type 1a/5; VDCC, voltage-d endent calcium channel; BDNF, brain-derived neurotrophic f ctor; Trk receptors, tyrosine ki ase receptors; TARP, transmem…”
BackgroundInfluentialAndrade, C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17f11567 · Cited by 91
Zhao, J., Verwer, R. W. H., van Wamelen, D. J., Qi, X.-R., Gao, S.-F., Lucassen, P. J., & Swaab, D. F. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.06.017 · Cited by 83 · cited 1×
“In fact, it has been suggested that a glutamate neurotransmission dysregulation may be the basis of suicidal cognitive biases, explaining the benefits of ketamine treatment [53,143].”
BackgroundKetamine for Depression, 3: Does Chirality Matter?: (Clinical and Practical Psychopharmacology)
Andrade, C. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17f11681 · Cited by 78
Fanelli, G., & Serretti, A. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.007 · Cited by 52
Cited by
Understanding the Complex of Suicide in Depression: from Research to Clinics
Orsolini, L., Latini, R., Pompili, M., Serafini, G., Volpe, U., Vellante, F., Fornaro, M., Valchera, A., Tomasetti, C., Fraticelli, S., et al. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0171 · Cited by 406
Self-citationPrevalence of post-traumatic stress disorder in the United States: a systematic literature review
Schein, J., Houle, C., Urganus, A., Cloutier, M., Patterson-Lomba, O., Wang, Y., King, S., Levinson, W., Guérin, A., Lefebvre, P., et al. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1978417 · Cited by 288
The lethality of suicide methods: A systematic review and meta-analysis
Cai, Z., Junus, A., Chang, Q., & Yip, P. S. F. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.12.054 · Cited by 155
Esketamine for Treatment-Resistant Depression: A Review of Clinical Evidence (Review)
Vasiliu, O. (2023) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2023.11810 · Cited by 82
Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System
Tomasetti, C., Montemitro, C., Fiengo, A. L. C., Santone, C., Orsolini, L., Valchera, A., Carano, A., Pompili, M., Serafini, G., Perna, G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190312102444 · Cited by 44
Self-citation
Metadata
- Authors
- De Berardis, D., Fornaro, M., Valchera, A., Cavuto, M., Perna, G., Di Nicola, M., Serafini, G., Carano, A., Pompili, M., Vellante, F., Orsolini, L., Fiengo, A., Ventriglio, A., Yong-Ku, K., Martinotti, G., Di Giannantonio, M., & Tomasetti, C.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-09-23
- Volume
- 19
- Issue
- 10
- Pages
- 2888
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2890611676
- Cited by
- 174
- References
- 43
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.